Hope McClaine Cottrill, MD

Gynecologic Oncology
Gender: Female
4.9 of 5 (142 Ratings)
Accepting New Patients

Clinical Focus

Gynecologic Cancers, Laser Surgery, Ovarian Cancer and Ovarian Masses, Radical Pelvic Surgery, Robotic Gynecologic Cancer Surgery, Trophoblastic Disease, Uterine Cancer, Uterine Masses

Practice Locations

A:
Baptist Health Medical Group Gynecologic Oncology
1700 Nicholasville Road, Suite 1100
Lexington, KY 40503
859-278-5671 859-278-5978

Education

Medical School

University of Kentucky College of Medicine

Residency

University of Kentucky Hospital

Residency

University of Kentucky College of Medicine

Fellowship

University of South Florida

Board Certifications

Gynecologic Oncology

American Board of Obstetrics and Gynecology

-

American Board of Obstetrics and Gynecology

Hospital Affiliations

  • Baptist Health Louisville
  • Baptist Health Richmond
  • Baptist Health Lexington

Philosophy of Care

Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.

Reviews

Patient Experience Ratings

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Overall Rating
4.9 out of 5 (142 Ratings)
Review Categories
Patient Comments

Research

  • Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Cervical Carcinoma

    AI3818-US-002: A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects with Recurrent or Metastatic Endometrial,

    Trial Details
  • Low Grade Ovarian Serous Adenocarcinoma

    NRG-GY019 -A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

    Trial Details

About Hope McClaine Cottrill